ReThink Medical attracts $3 mln Series A

ReThink Medical, a heart failure medical device and digital health company, has raised $3 million in Series A funding. Emergent Medical Partners led the round with participation from Norwich Ventures and Launch Capital. In conjunction with the funding, Bob Brownell, managing director at EMP, has been added to ReThink Medical’s board of directors.

Source: Press Release